A Comparative Study On Quality of Life Between Thrombolysed and Non-Thrombolysed Ischemic Stroke Patients
Pharmaceutical Science-Pharm-D
DOI:
https://doi.org/10.22376/ijlpr.2023.13.4.P61-P69Keywords:
Ischemic stroke, Quality of life, Thrombolysis, Non-thrombolysis, Hemiparesis.Abstract
Stroke is one of the leading causes of morbidity and mortality worldwide. Ischemic strokes are the most common variety of strokes caused by either thrombosis or embolism. In addition, they account for 50% – 85% of cerebrovascular accidents. Thrombolysis is used in the treatment of acute ischemic stroke. The current study examined the clinical profile and assessed risk factors, adverse events, and quality of life between thrombolytic and non-thrombotic ischemic stroke patients. A prospective observational study was conducted in a tertiary care Hospital with a sample size of 106 Ischemic stroke patients for four months. The patients were enrolled based on inclusion and exclusion criteria and were interviewed using a semi-structured questionnaire. Quality of life was assessed using Stroke specific quality of life scale (SSQOL). The results showed that the incidence of stroke is most common in the age group of 61-80 years, with a mean age of 59.9 years. Hypertension was the leading risk factor in 74.4% of cases. Speech Involvement (74.5%) was the most common presentation, followed by Hemiparesis, Altered sensorium. In our study, patients presenting to hospital >4.5hrs were higher, and the quality of life between thrombolysis and non-thrombolysis patients were nearly identical. However, there was applied statistically significant distinction in energy, mobility, self-care, vision, and work items of the SSQoL scale. We conclude that the two groups had no major variations within the primary outcome of QOL. Thus, the current study tends to expect that patients with non-thrombolytic therapy will have a worse quality of life due to the greater initial stroke severity. Therefore, medical care appears to be of more importance in achieving a higher quality of life in ischemic thrombolysis stroke patients who reply to this therapy.
References
Strong K, Mathers C, Bonita R. Preventing stroke: saving lives worldwide. Lancet Neurol. 2007;6(2):182-7. doi: 10.1016/S1474-4422(07)70031-5, PMID 17239805.
Alotaibi SM, Alotaibi HM, Alolyani AM, Abu Dali FA, Alshammari AK, Alhwiesh AA, et al. Assessment of the stroke-specific quality-of-life scale in KFHU, Khobar: A prospective cross-sectional study. Neurosciences (Riyadh, Saudi Arabia), 2/2012. 2021;26(2):171-8. Doi.10.17712/nsj.2021.2.20200126. doi: 10.17712/nsj.2021.2.20200126, PMID 33814370.
Ringer A, Tackla R, Mayfield Clinic. Vol. 931. Cincinnati; 2018.
Yousufuddin M, Young N. Aging and ischemic stroke. Aging (Albany, NY). 15/05/2019;11(9):2542-4. doi: 10.18632/aging.101931, PMID 31043575.
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765-74. doi: 10.1016/0140-6736(90)90878-9, PMID 1969518.
Magudeeswaran R. Study of clinical profile & risk factors in acute ischemic stroke in Government Vellore Medical College Hospital, Vellore [doctoral dissertation], Government Vellore Medical College. Vellore; 1/4/2016.
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355-69. doi: 10.1016/S1474-4422(09)70025-0, PMID 19233729.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST.Trial of Org 10172 in Acute Stroke Treatment. Stroke (PUB MED). 1/01/1993;24:35-41.
Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed Tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293-8. doi: 10.1016/S0140-6736(07)60151-2, PMID 17258669.
Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, Reeves MJ, et al. Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: a Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2018;49(3):e111-22. doi: 10.1161/STR.0000000000000160. PMID 29367333.
Berglund A, Svensson L, Wahlgren N, von Euler M, HASTA collaborators. Face Arm Speech Time Test used in the prehospital setting, better in the ambulance than in the emergency medical communication center. Cerebrovasc Dis. 2014;37(3):212-6. doi: 10.1159/000358116, PMID 24576912.
Baatiema L, Chan CKY, Sav A, Somerset S. Interventions for acute stroke management in Africa: a systematic review of the evidence. Syst Rev. 2017;6(1):213. doi: 10.1186/s13643-017-0594-4, PMID 29065915.
Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, et al. Older age does not increase risk of hemorrhagic complications after intravenous and intra-arterial thrombolysis for acute stroke. J Stroke Cerebrovasc Dis. 2008;17(5):266-72. doi: 10.1016/j.jstrokecerebrovasdis.2008.03.003.
Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014, Issue 7;2016(1): Art No. CD000213. doi: 10.1002/14651858.CD000213.pub3.
De Weerd L, Luijckx GJ, Groenier KH, van der Meer K. Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol. 2012;12:61. doi: 10.1186/1471-2377-12-61, PMID 22835054.
Baig MU, Bodle J. Thrombolytic therapy. In: Stat pearls. Treasure Island, (FL): StatPearls Publishing; 2022 Jan 5. PMID 324913.
Van Heugten C. M, Barbara A Wilson. Cognition, emotion, and fatigue post-stroke. Clinical pathways in stroke rehabilitation. Berlin: Springer, 15/01/2021. doi: 10.1007/978-3-030-58505-1_12.
Ramos-Lima MJM, Brasileiro IC, Lima TL, Braga-Neto P. Quality of life after stroke: impact of clinical and socio-demographic factors. Clin (S Paulo Brazil), ISSN- 1980-5322. Oct 8, 2018;73:e418. doi: 10.6061/clinics/2017/e418, PMID 30304300.
Pedersen SG, Friborg O, Heiberg GA, Arntzen C, Stabel HH, Thrane G, et al. Stroke-Specific Quality of Life one-year post-stroke in two Scandinavian country-regions with different organization of rehabilitation services: a prospective study. Disabil Rehabil. 2021;43(26):3810-20. doi: 10.1080/09638288.2020.1753830. PMID 32356473.
Alotaibi SM, Alotaibi HM, Alolyani AM, Abu Dali FA, Alshammari AK, Alhwiesh AA, et al. Assessment of the stroke-specific quality-of-life scale in KFHU, Khobar: A prospective cross-sectional study. Neurosciences (Riyadh). 2021;26(2):171-8. doi: 10.17712/nsj.2021.2.20200126, PMID 33814370.
Punna S, D S, Mohammad AB, Balla KS, K A, Edem S, et al. Clinical profile of patients with stroke in a tertiary hospital setting in rural Telangana. Natl J Physiol Pharm Pharmacol. 2020;10(6):473-7. doi: 10.5455/njppp.2020.10.03078202028032020.
Sivanesan P. Clinical profile of stroke patients in South Tamil Nadu tertiary Care Hospital – A cross-sectional study. Int J Sci Study;09/2019; 7(6):83-6.
Raghuvanshi S. A study of clinical profile and subtypes of acute ischemic stroke in a tertiary Care Center. Int J Sci Study. 2016 Aug 1;4(5):128-31.
Naik M, Rauniyar RK, Sharma UK, Dwevedi S, Karki DB, Samual JR. Clinic-radiological profile of stroke in eastern Nepal: A computed tomographic study. Kathmandu Univ Med Council. 2006;4(14):161-6.
Aiyar A. Study of clinic-radiological correlation in cerebrovascular stroke. Gujarat Med J. 1999;52:58-63.
Kingsly Jebasingh Y, Sivanesan P. Clinical profile of stroke patients in South Tamil Nadu tertiary Care Hospital – A cross-sectional study. Int J Sci Study;09/2019:7(6).
Sangramvurumadla. Rakshith v. A study on symptoms, risk factors and prescribing pattern of drugs used in stroke patients. Int J Pharm Pharm Sci. Jan 2015;7(1):421-6.
Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7(10):915-26. doi: 10.1016/S1474-4422(08)70193-5, PMID 18722812.
Garvey WT, Hermayer KL. Clinical implications of the insulin resistance syndrome. Clin Cornerstone. 1998;1(3):13-28. doi: 10.1016/s1098-3597(98)90015-1, PMID 10682170.
O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al.. Risk factors for ischaemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. PMID 20561675.
Yamini M. A study of clinical profile of patients undergoing stroke thrombolysis in a Tertiary Care Hospital; 2019 ([doctoral dissertation]. Chennai: Stanley Medical College).
De Weerd L, Luijckx GJ, Groenier KH, van der Meer K. Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol. 2012 Dec;12(1):61. doi: 10.1186/1471-2377-12-61, PMID 22835054.
Eby matew, chandrikaC, et.al. A prospective observational study on Prescribing trends and adverse drug reaction in stroke patients. Intern J Pharm Pharm Sci. 2017;9(7), ISSN- 0975-149.
Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M., et al. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: a randomized, controlled trial. Stroke. 2009;40(9):3073-8. doi: 10.1161/STROKEAHA.109.549808, PMID 19661478.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dr. Vankodoth Sireesha, V. Sushma, K. Bhavitha Naga Sai, Sumaiya Sana, M. Pratibha, M. Sunil Kumar, chintalapally kanna reddy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
